Arthur Tzianabos's Net Worth
Arthur Tzianabos's net worth is estimated to be at least $3,550,869.36 as of 04/03/2026. CoreStreet's estimation of Arthur Tzianabos's net worth is based on their sale of stock and current holding of stock.
Arthur Tzianabos is Insider at Stoke Therapeutics Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 4,355 units of STOK stock on 03/10/2026. Their biggest sale was on 11/23/2020 when they sold 20,000 units of Stoke Therapeutics Inc stock for $920,600.00. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $3,550,869.36
Most recent insider trade:
- March 10, 2026
Arthur Tzianabos's Insider Trading History
| Stoke Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 10, 2026 | Insider | 4,355 | $40.00 | Sell | $174,200.00 |
Feb. 19, 2021 | Director | 10,000 | $60.67 | Sell | $606,700.00 |
Nov. 23, 2020 | Director | 20,000 | $46.03 | Sell | $920,600.00 |
| Homology Medicines Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 9, 2023 | Director | 10,616 | $1.39 | Sell | $14,756.24 |
Jan. 5, 2022 | CEO | 5,354 | $3.78 | Sell | $20,238.12 |
Jan. 2, 2020 | CEO | 12,500 | $20.50 | Sell | $256,250.00 |
Dec. 2, 2019 | CEO | 12,500 | $16.25 | Sell | $203,125.00 |
Nov. 29, 2019 | CEO | 12,500 | $16.04 | Sell | $200,500.00 |
Oct. 1, 2019 | CEO | 12,500 | $17.40 | Sell | $217,500.00 |
Sept. 3, 2019 | CEO | 12,500 | $18.75 | Sell | $234,375.00 |
Aug. 1, 2019 | CEO | 12,500 | $17.37 | Sell | $217,125.00 |
July 1, 2019 | CEO | 12,500 | $18.98 | Sell | $237,250.00 |
June 3, 2019 | CEO | 12,500 | $19.86 | Sell | $248,250.00 |